Diabetes - GLP-1 agonists should be primarily considered in patients with type 2 diabetes with suboptimal glycaemic control despite maximal tolerated dose of metformin (+/- other agents) especially where weight loss is desired and/or significant stroke risk is present
Contact Davis Aesthetic Weight Loss today to learn more about your options and discover a medically supervised weight loss program designed to help you feel stronger, leaner, and more in controlwithout guessing your way through the process.
DISCLAIMER FOR USE: All products available for purchase on the Website are intended for laboratory research purposes only and are not intended for human or animal consumption
One such breakthrough approach involves the use of GLP-1-based therapies, like Ozempic
These are personalized for each individual by a medical provider, and therefore, actual costs will vary
Responses were sorted based on inquiry type, and were then analyzed to determine the most important findings of the study.